FDA Vaccine Chief Vinay Prasad Set to Leave Post Next Month [Yahoo! Finance]
uniQure N.V. - Ordinary Shares (QURE)
Last uniqure n.v. - ordinary shares earnings: 4/29 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
uniqure.com/investors-newsroom/overview.php
Company Research
Source: Yahoo! Finance
Source: US Food and Drug Administration (Bloomberg) -- The head of the US Food and Drug Administration's division of vaccines and gene therapies is leaving the agency after a tumultuous tenure, sending biotech shares higher in late trading on Friday. Vinay Prasad will depart the Center for Biologics Evaluation and Research next month to return to his prior career in academia. He was known for overruling his own scientific review staff at times and taking a confrontational approach that critics said would stymie scientific innovation and slow drug approvals. Most Read from Bloomberg US Sinking of Iranian Warship Piles Pressure on India's Modi China Tells Top Refiners to Halt Diesel and Gasoline Exports ‘As Dead as Fried Chicken': Why Trump Finally Fired Noem Oracle Plans Thousands of Job Cuts in Face of AI Cash Crunch Modi Stresses Dialog, Diplomacy After US Sinks Iran Warship News of Prasad's departure sent shares of some biotech firms soaring. UniQure NV jumped 55%
Show less
Read more
Impact Snapshot
Event Time:
QURE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QURE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QURE alerts
High impacting uniQure N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
QURE
News
- uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QUREPR Newswire
- FDA's controversial vaccine chief will exit agency next month [CNN]CNN
- FDA Vaccine Chief Vinay Prasad Set to Leave Post Next Month [Yahoo! Finance Canada]Yahoo! Finance Canada
- FDA's controversial vaccine chief will exit agency next month [CNN]CNN
- UPCOMING DEADLINE: uniQure N.V. (QURE) Securities Fraud Class Action – April 13, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLPGlobeNewswire
QURE
Earnings
- 11/10/25 - Miss
QURE
Sec Filings
- 3/6/26 - Form 4
- 3/6/26 - Form 4
- 3/6/26 - Form 4
- QURE's page on the SEC website